Acteurs : Acteur Vincent DANCOURT

0
home-8766277
Nom
Dr Vincent DANCOURT
Coordonnées
Affiliation(s)
Equipe de recherche
Equipe B12 – Vincent DANCOURT •
Axes du CGE
1 : Indicateurs de santé et évaluation des pratiques en cancérologie
Projets
Equipe B12

2007 – PARLE (porteur : Vincent Dancourt)
What is the effect of a reminder sent after mailing of the screening test on the compliance and cost-effectiveness of colorectal cancer screening with faecal occult blood tests
Publications


Dancourt V, Lejeune C, Lepage C, Gailliard MC, Meny B, Faivre J. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer. 2008 Oct;44(15):2254-8. Epub 2008 Aug 27.

pixel-4212895
Lepage C, Bouvier AM, Binquet C, Dancourt V, Coatmeur O, Faivre J. Are the recommendations of the French consensus conference on the management of colon cancer followed up? Eur J Cancer Prev. 2006 Aug;15(4):295-300.

pixel-4212895
Bouvier AM, Remontet L, Jougla E, Launoy G, Grosclaude P, Buemi A, Tretarre B, Velten M, Dancourt V, Menegoz F, Guizard AV, Mace Lesec’h J, Peng J, Bercelli P, Arveux P, Esteve J, Faivre J. Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):877-81.

pixel-4212895
Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, Dassonville F, Bonithon-Kopp C. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004 Jun;126(7):1674-80.

Lejeune C, Arveux P, Dancourt V, Fagnani F, Bonithon-Kopp C, Faivre J. A simulation model for evaluating the medical and economic outcomes of screening strategies for colorectal cancer. Eur J Cancer Prev. 2003 Feb;12(1):77-84.
home-8766277pixel-4212895uguest-6158399 poweredby-6331408